Alex J. Liu

Immunotherapy and chimeric antigen receptor T-cell therapy in hepatocellular carcinoma.

M. Borad, T. Bekaii-Saab, Pedro Luiz Serrano Uson Junior, 2021, Chinese clinical oncology.

The impact of genetic aberrations on response to radium‐223 treatment for castration‐resistant prostate cancer with bone metastases

T. Ho, A. Bryce, Parminder Singh, 2022, The Prostate.

Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer

H. Linden, V. Wu, V. Gadi, 2021, Breast Cancer Research and Treatment.

Chemoimmunotherapy as the First-Line Treatment for Patients With Extensive-Stage Small-Cell Lung Cancer and an ECOG Performance Status 2 or 3.

R. Manochakian, K. Leventakos, V. Ernani, 2023, Clinical lung cancer.

Efficacy of Checkpoint Inhibitors in Neuroendocrine Neoplasms

T. Hobday, T. Halfdanarson, J. Gile, 2021, Pancreas.

Neuroendocrine Carcinoma of the Anus and Rectum: Patient Characteristics and Treatment Options.

T. Bekaii-Saab, J. Ashman, T. Hobday, 2020, Clinical colorectal cancer.

Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors.

T. Hobday, T. Halfdanarson, A. Kendi, 2021, The oncologist.

Chemoimmunotherapy in patients with extensive‐stage small cell lung cancer and a poor performance status

R. Manochakian, K. Leventakos, V. Ernani, 2023, Cancer.